Respiratory complications are the most common adverse event during deep sedation, with studies indicating that 40 – 70% of patients receiving sedation may experience hypoxia. To address this common issue, the American Society of Anesthesiologists (ASA) guidelines recommend monitoring end-tidal carbon dioxide (ETCO₂) during moderate and deep sedation.

However, current ETCO₂ monitoring methods during sedation often prove to be unreliable.

The AERIS Airway™ from Airway Innovations transforms standard oropharyngeal (OPAs) and nasopharyngeal (NPAs) airways into advanced dual-function systems. The advanced AERIS airways provide better oxygenation while capturing reliable ETCO₂ data in real-time, enabling clinicians to detect respiratory compromise before it becomes a serious issue.

Better Oxygenation. Safer Airway Management.

Unlike traditional setups, AERIS design offsets the oxygen delivery port from the CO₂ detection port. This allows for accurate ETCO₂ monitoring at the supraglottis with minimal oxygen dilution, resulting in a clear, reliable waveform on standard capnography monitors while maintaining a smooth laminar oxygen flow through the airway device.

The AERIS can deliver high concentrations of oxygen efficiently, achieving up to 80% FiO₂ at low rates and up to 100% at moderate flow rates. By optimizing oxygen delivery and reducing dilution, clinicians can maintain adequate oxygenation while using less oxygen overall.

The AERIS Airway™ sets a new standard in deep I.V. sedation and TIVA procedures by improving oxygenation and patient safety.

Key Features of the AEIRS Airway™

• Simultaneously delivers oxygen and captures reliable ETCO₂ data in real time
• Minimizes oxygen dilution for more accurate CO₂ waveform monitoring
• Delivers up to 80% FiO₂ at 2–4 L/min and up to 100% at 6–10 L/min
• Fits 95% of adult Guedel OPAs and NPAs
• Promotes efficient oxygenation with lower overall oxygen use
• Supports earlier detection of respiratory compromise
• Modernizes standard airway devices without adding complexity

For more information or a demonstration of the AERIS Airway™, contact your local MED Alliance Group sales representative, call 888-891-1200 or email us.

MED Alliance Group is a medical device distributor dedicated to meeting the needs of our clinical customers and manufacturing partners since 1998. We specialize in the sales, marketing, importation, logistics and distribution of innovative, high-quality and cost-effective products found in anesthesia and respiratory, blood and transfusion therapy, EMS and emergency room, interventional radiology and cath lab, iv and vascular, as well as NICU and PICU.

Please follow us on LinkedIn, Facebook and Twitter for MED Alliance product updates.